Literature DB >> 21330482

Chronic GVHD: B cells come of age.

Gérard Socié1.   

Abstract

Year:  2011        PMID： 21330482     DOI： 10.1182/blood-2010-12-322297

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.

Authors:  Suzanne van Dorp; Henrike Resemann; Liane te Boome; Floor Pietersma; Debbie van Baarle; Frits Gmelig-Meyling; Roel de Weger; Eefke Petersen; Monique Minnema; Henk Lokhorst; Saskia Ebeling; Scott J P Beijn; Edward F Knol; Marijke van Dijk; Ellen Meijer; Jürgen Kuball
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

Review 2.  Mesenchymal stromal cells: a new tool against graft-versus-host disease?

Authors:  Frédéric Baron; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

3.  H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.

Authors:  Bita Sahaf; Yang Yang; Sally Arai; Leonard A Herzenberg; Leonore A Herzenberg; David B Miklos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

4.  Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation.

Authors:  Erin Gatza; Sung Won Choi
Journal:  Int J Hematol Oncol       Date:  2015-08

Review 5.  Current issues in chronic graft-versus-host disease.

Authors:  Gérard Socié; Jerome Ritz
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

Review 6.  B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Mateja Kralj Juric; Maxim Shevtsov; Petra Mozes; Justyna Ogonek; Rachel E Crossland; Anne M Dickinson; Hildegard T Greinix; Ernst Holler; Eva M Weissinger; Gabriele Multhoff
Journal:  Front Immunol       Date:  2017-01-16       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.